Natalia Słabiak-Błaż

senior lecturer

Medical University of Silesia

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Natalia Słabiak-Błaż is a senior lecturer at the Medical University of Silesia in Poland. Her research focuses on kidney transplantation, investigating topics such as cardiovascular complications, immunosuppression, and kidney donor risk factors. Recent articles authored by her include studies on kidney donor risk index, intestinal permeability post-transplantation, and the evaluation of different preservation solutions for kidney grafts.

Articles (9)

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Joanna Musialik

Assistant Professor

Medical University of Silesia

POLAND

View details

Magdalena Bartmańska

Medical University of Silesia

POLAND

View details

Andrzej Więcek

Medical University of Silesia

POLAND

View details

Henryk Karkoszka

Medical University of Silesia

POLAND

View details

Aureliusz Kolonko

Associate Professor

Medical University of Silesia

POLAND

View details

Robert Król

Head of Department

Medical University of Silesia

POLAND

View details

Grzegorz Piecha

Medical University of Silesia

POLAND

View details

Agata Kujawa-Szewieczek

Medical University of Silesia

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Natalia Słabiak-Błaż

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Kidney Donor Risk Index and Cardiovascular Complications in a Long-Term Follow-Up Observation

Association between Kidney Donor Risk Index, kidney graft function and histological changes in early post-transplant graft biopsy

Intestinal Permeability in Patients Early after Kidney Transplantation Treated with Two Different Formulations of Once-Daily Tacrolimus

Clinical Outcomes of Transplanted Kidneys from Deceased Donors Using Different Generic Preservation Solutions

The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation

Endogenous Mammalian Cardiotonic Steroids—A New Cardiovascular Risk Factor?—A Mini-Review

Clinical insights into the role of immunosuppression and its disturbances in solid organ transplant recipients with coronavirus disease 2019

Changes in office blood pressure control, augmentation index, and liver steatosis in kidney transplant patients after successful hepatitis C infection treatment with direct antiviral agents.

The preliminary results of bortezomib used as a primary treatment for an early acute antibody-mediated rejection after kidney transplantation - a single-center case series.

Collaborators (8)

Joanna Musialik

Magdalena Bartmańska

Andrzej Więcek

Henryk Karkoszka

Aureliusz Kolonko

Robert Król

Grzegorz Piecha

Agata Kujawa-Szewieczek

Make your next move.